Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Operating Activities
Net income	$ 3,691	$ 2,766
Items not requiring (providing) cash
Accretion of premiums and discounts on securities, net	80	0
Depreciation and amortization	712	683
Expense related to share based compensation plans	205	104
Expense related to ESOP	210	210
Provision for loan losses	201	75
Increase in value of bank-owned life insurance	(220)	(227)
Gain on sale of loans	(54)	(88)
Proceeds from sale of loans held for sale	2,621	3,860
Originations of loans held for sale	(2,567)	(3,772)
(Gain) Loss on sale or write down of foreclosed assets	(15)	12
Amortization of mortgage servicing rights	28	5
Net change in accrued interest receivable and other assets	(886)	(1,660)
Net change in accrued expenses and other liabilities	(67)	773
Net cash provided by operating activities	3,939	2,741
Securities available for sale:
Maturities, prepayments and calls	0	7,249
Purchases	(42,514)	(6,248)
Net change in loans	(25,138)	(3,909)
Purchases of premises and equipment	(617)	(674)
Proceeds from sale of foreclosed assets	285	9
Net cash used in investing activities	(67,984)	(3,573)
Financing Activities
Net change in deposits	48,365	42,048
Net change in securities sold under repurchase agreements	4,314	6,795
Net change in FHLB overnight borrowings	12,200	(19,500)
Repayments of long-term borrowings	(83)	(15,098)
Cash dividends paid on common stock	(2,156)	(1,846)
Net cash provided by financing activities	62,640	12,399
(Decrease) Increase in Cash and Cash Equivalents	(1,405)	11,567
Cash and Cash Equivalents, Beginning of Period	14,315	11,541
Cash and Cash Equivalents, End of Period	12,910	23,108
Supplemental Cash Flows Information
Interest paid on deposits and borrowings	2,046	1,370
Federal income taxes paid	665	448
Supplemental Disclosure of Non-Cash Investing and Financing Activities
Transfers from loans to foreclosed assets held for sale	$ 280	$ 0